ArticleORL; journal for oto-rhino-laryngology and its related specialties2023

Characterizing Adverse Events of Biologic Treatment of T2 Disease: A Disproportionality Analysis of the FDA Adverse Event Reporting System.

Taylor J Stack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.